Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells

Despite recent advances in clinical stem cell therapy applications based on human pluripotent stem cells (hPSCs), potential teratoma formation due to the presence of residual undifferentiated hPSCs remains a serious risk factor that challenges widespread clinical application. To overcome this risk,...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Young-Hyun, Kim, Jumee, Jeong, Ho-Chang, Kim, Seong-Min, Kim, Yun-Jeong, Park, Soon-Jung, Moon, Sung-Hwan, Cha, Hyuk-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692041/
https://www.ncbi.nlm.nih.gov/pubmed/33121085
http://dx.doi.org/10.3390/biomedicines8110453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692041/
https://www.ncbi.nlm.nih.gov/pubmed/33121085
http://dx.doi.org/10.3390/biomedicines8110453

Ejemplares similares